Related Experiment Video

Updated: Mar 24, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models

Peican Zhu1, Hamidreza Montazeri Aliabadi2,3, Hasan Uludağ3

  • 1Department of Electrical and Computer Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.

Scientific Reports
|March 19, 2016
PubMed

Insights

This study identifies key genes in breast cancer signaling pathways. JAK2, Stat3, and Myc show potential as therapeutic targets, with some requiring customized treatment approaches.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Oncology

Background:

  • Aberrant signaling pathways are hallmarks of cancer, driving tumor progression and therapeutic resistance.
  • Identifying vulnerable components within these pathways is crucial for developing targeted cancer therapies.
  • Breast cancer signaling pathways exhibit significant heterogeneity among patients, complicating treatment strategies.

Purpose of the Study:

  • To develop novel stochastic logical models for analyzing signaling pathway vulnerabilities in breast cancer.
  • To computationally identify key regulatory genes influencing cell viability in breast cancer signaling cascades.
  • To assess the potential of identified genes as therapeutic targets for breast cancer treatment.

Main Methods:

  • Derivation of an original signaling pathway from published breast cancer literature.
  • Development and application of stochastic logical models to analyze component vulnerabilities.
  • Computational prediction and experimental validation using siRNA-mediated gene silencing and cell viability assays.

Main Results:

  • Genes elF4E and NFkB showed minimal impact on relative cell viability.
  • JAK2, Stat3, S6K, JUN, FOS, Myc, and Mcl1 were identified as effective candidates influencing cell growth.
  • Vulnerability of targets like Myc and S6K varied with sub-pathway weights, suggesting a need for personalized therapy.

Conclusions:

  • Specific genes like JAK2, Stat3, and Myc are critical targets in breast cancer signaling.
  • Therapeutic targeting requires customization due to pathway heterogeneity and variable target vulnerability.
  • Universally effective therapeutic targets are those with consistently high vulnerability across diverse patient profiles.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K